vTv Therapeutics Inc. (VTVT) Key Metrics
VTVT valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $104.9M
- Enterprise value
- $22.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 2.8 10-yr median 20.4
- Price / book
- 1.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.21
VTVT key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsVTVT valuation Price multiples at each fiscal year-end price.
Price / book−20.0%
5.2
2025 · hover or tap a bar for each year
20162025
Free cash flow yield+24.3 pts
−7.5%
2025 · hover or tap a bar for each year
20162025
VTVT returns How much profit the business earns on the capital it uses.
Return on assets+32.8 pts
−42.1%
2025 · hover or tap a bar for each year
20162025
Asset turnover−100.0%
0.00
2025 · hover or tap a bar for each year
20162025
VTVT per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−100.0%
$0.00
2025 · hover or tap a bar for each year
20162025
Earnings per share
−$3.20
2025 · hover or tap a bar for each year
20162025
Free cash flow per share
−$3.00
2025 · hover or tap a bar for each year
20162025
Book value per share+261.9%
$7.65
2025 · hover or tap a bar for each year
20162025
Shares outstanding+46.0%
8.4M
2025 · hover or tap a bar for each year
20162025
VTVT financial health Debt, liquidity and how easily interest is covered.
Net debt−$52.4M
−$88.9M
2025 · hover or tap a bar for each year
20162025
Current ratio+84.5%
13.54
2025 · hover or tap a bar for each year
20162025
VTVT efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding+13,341 days
23,622 days
2025 · hover or tap a bar for each year
20162025
VTVT valuation history
Fiscal year-endToday10-year median
VTVT returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
VTVT debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
VTVT cash returned to shareholders
DividendsBuybacksFree cash flow
VTVT price vs earnings per share
Share price at year-endEPS (right axis)
VTVT key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $336.9M | $79.7M | $24.0M | $50.9M | $62.3M | $87.7M | — | — | — | $1.84B |
| Enterprise value | $247.9M | $43.1M | $15.1M | $39.5M | $49.9M | $82.8M | — | — | — | $1.81B |
| Price / sales | — | 78.4 | — | 25.2 | 15.6 | 13.7 | — | — | — | — |
| Price / book | 5.2 | 6.5 | — | — | — | — | — | — | — | — |
| EV / sales | — | 42.4 | — | 19.6 | 12.4 | 12.9 | — | — | — | — |
| Earnings yield | −8.0% | −23.2% | −84.5% | −37.6% | −20.8% | −9.7% | — | — | — | −0.9% |
| Free cash flow yield | −7.5% | −31.8% | −79.6% | −30.0% | −31.0% | −20.5% | — | — | — | −2.6% |
| Dividend yield | — | — | — | — | — | — | — | — | — | 0.0% |
| Shareholder yield (dividends + buybacks) | — | — | — | 0.0% | — | 0.0% | — | — | — | 0.0% |
| Share price at fiscal year-end | $39.99 | $13.81 | $11.50 | $26.52 | $39.80 | $74.40 | $68.00 | $106.00 | $240.40 | $193.20 |
| Per share | ||||||||||
| Revenue per share | $0.00 | $0.18 | $0.00 | $1.05 | $2.56 | $5.44 | — | — | — | $0.07 |
| Earnings per share | −$3.20 | −$3.20 | −$9.71 | −$9.98 | −$8.29 | −$7.21 | — | — | — | −$1.71 |
| Operating cash flow per share | −$3.00 | −$4.39 | −$9.15 | −$7.94 | −$12.33 | −$15.27 | — | — | — | −$5.05 |
| Free cash flow per share | −$3.00 | −$4.39 | −$9.15 | −$7.95 | −$12.33 | −$15.27 | — | — | — | −$5.06 |
| Cash per share | $10.56 | $6.37 | $4.53 | $6.32 | $8.57 | $4.88 | — | — | — | $5.40 |
| Book value per share | $7.65 | $2.11 | −$11.84 | −$5.59 | −$6.22 | −$67.97 | — | — | — | −$9.53 |
| Tangible book value per share | $7.65 | $2.11 | −$11.84 | −$5.59 | −$6.22 | −$67.97 | — | — | — | −$9.53 |
| Dividends per share | — | — | — | — | — | — | — | — | — | $0.00 |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 | $0.02 | — | — | — | $0.01 |
| Debt per share | — | $0.03 | $0.25 | $0.37 | $0.60 | $0.78 | — | — | — | $2.03 |
| Shares outstanding | 8.4M | 5.8M | 2.1M | 1.9M | 1.6M | 1.2M | — | — | — | 9.5M |
| Change in shares outstanding | +46.0% | +176.8% | +8.6% | +22.6% | +32.9% | — | — | — | — | +15.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −70.4% | — | — | — | — | — | — | — | — | — |
| Return on assets (ROA) | −42.1% | −74.9% | −91.5% | −65.3% | −64.5% | −70.7% | −246.1% | −43.4% | −39.2% | −22.4% |
| Return on tangible assets | −30.0% | −48.2% | −183.8% | −57.7% | −51.0% | −57.5% | −236.8% | −92.4% | −57.8% | −30.0% |
| Free cash flow margin | — | — | — | −756.5% | −482.1% | −280.6% | −835.3% | −216.0% | — | — |
| Financial health | ||||||||||
| Total debt | — | $169,000 | $529,000 | $716,000 | $932,000 | $915,000 | $7.1M | $15.7M | $19.6M | $19.4M |
| Cash & short-term investments | $88.9M | $36.7M | $9.4M | $12.1M | $13.4M | $5.7M | $1.8M | $1.7M | $11.8M | $51.5M |
| Net debt | −$88.9M | −$36.6M | −$8.9M | −$11.4M | −$12.5M | −$4.8M | $5.3M | $14.0M | $7.8M | −$32.1M |
| Debt / equity | — | 0.01 | — | — | — | — | — | — | — | — |
| Debt / assets | — | 0.00 | 0.05 | 0.02 | 0.04 | 0.06 | 0.77 | 1.84 | 0.70 | 0.36 |
| Current ratio | 13.54 | 7.34 | 1.00 | 3.52 | 1.84 | 1.13 | 0.21 | 0.18 | 0.76 | 4.56 |
| Quick ratio | 13.54 | 7.34 | 1.00 | 3.51 | 1.83 | 1.07 | 0.19 | 0.18 | 0.75 | 4.56 |
| Interest coverage | — | — | — | — | — | -17.1 | -11.4 | -6.0 | -16.4 | -138.2 |
| Working capital | $83.3M | $32.9M | $38,000 | $19.4M | $7.1M | $825,000 | −$10.5M | −$15.4M | −$6.6M | $40.7M |
| Invested capital | −$24.5M | −$24.4M | −$33.6M | −$22.1M | −$22.2M | −$84.9M | −$43.7M | −$68.8M | −$143.2M | −$123.0M |
| Tangible asset value | $64.4M | $14.3M | −$18.5M | $5.8M | $15.2M | $3.8M | −$8.8M | −$82.9M | −$151.0M | −$90.9M |
| Net current asset value | $64.4M | $14.1M | −$18.9M | −$305,000 | $5.4M | −$3.8M | −$15.3M | −$87.9M | −$158.6M | −$93.3M |
| Graham net-net per share | $7.53 | $2.22 | −$9.61 | −$3.10 | $2.08 | −$4.20 | — | — | — | −$9.84 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | $992,000 | — | $0 | $0 |
| Share buybacks (net) | — | — | — | $0 | — | $0 | $0 | $0 | $0 | $0 |
| Capex / revenue | — | 0.0% | 0.0% | 1.0% | 0.5% | 0.3% | 2.5% | 0.0% | 19.6% | 13.7% |
| Capex / depreciation | 0.00 | 0.00 | 0.00 | 0.23 | 0.24 | 0.22 | 1.79 | 0.02 | 0.29 | 0.33 |
| Stock-based compensation / revenue | — | 271.1% | 17,533.3% | 63.0% | 58.8% | 15.7% | 54.9% | 21.5% | 1,252.6% | 416.6% |
| R&D / revenue | — | 1,135.3% | 151,055.6% | 612.3% | 332.7% | 171.7% | 547.0% | 185.3% | 13,622.0% | 7,215.8% |
| SG&A / revenue | — | 1,342.3% | 132,300.0% | 604.6% | 308.2% | 113.0% | 308.9% | 74.2% | 3,894.5% | 1,562.5% |
| Efficiency | ||||||||||
| Days sales outstanding | — | 29.4 | 253,837.2 | 1,128.0 | 9.8 | 4.6 | 0.3 | 117.4 | 10,034.4 | — |
| Days of inventory on hand | — | — | — | 228.1 | 965.8 | 10.3 | 6.0 | — | 0.7 | — |
| Days payables outstanding | 23,622.3 | 10,281.5 | 13,253.6 | 8,603.3 | 7,794.2 | 68.9 | 61.9 | 40.9 | 63.0 | 75.5 |
| Cash conversion cycle (days) | — | -10,252.1 | 240,583.7 | -7,247.2 | -6,818.6 | -53.9 | -55.6 | 76.5 | 9,972.1 | — |
| Receivables turnover | — | 12.40 | 0.00 | 0.32 | 37.26 | 78.70 | 1,105.60 | 3.11 | 0.04 | — |
| Payables turnover | 0.02 | 0.04 | 0.03 | 0.04 | 0.05 | 5.30 | 5.89 | 8.91 | 5.79 | 4.84 |
| Inventory turnover | — | — | — | 1.60 | 0.38 | 35.48 | 60.48 | — | 489.38 | — |
| Asset turnover | 0.00 | 0.04 | 0.00 | 0.07 | 0.20 | 0.53 | 0.31 | 0.68 | 0.01 | 0.01 |
| Average receivables | — | $82,000 | $6.3M | $6.2M | $107,500 | $81,500 | $2,500 | $4.0M | $8.0M | — |
| Average payables | $1.0M | $2.5M | $3.3M | $2.2M | $1.9M | $2.1M | $2.6M | $2.6M | $6.8M | $9.5M |
| Average inventory | — | — | — | $57,500 | $235,500 | $310,500 | $250,000 | — | $81,000 | $0 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from VTVT's annual financial statements (latest annual report filed March 10, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
VTVT valuation and financial ratios
vTv Therapeutics earned a return on equity of −70.4% in fiscal 2025. The share count fell 11.8% from 9.5M to 8.4M over 9 years.
See the VTVT income statement, the VTVT chart for price history, or the VTVT stock overview for the latest quote and news.
VTVT key metrics FAQ
What is vTv Therapeutics's return on equity?
vTv Therapeutics's return on equity (ROE) was −70.4% in fiscal 2025: net income of -$27.0 million on average shareholders' equity of $38.3 million.
What is vTv Therapeutics's free cash flow yield?
vTv Therapeutics generated -$25.3 million of free cash flow in fiscal 2025, a free cash flow yield of −7.5% on its market value at year-end ($336.9 million).
What is vTv Therapeutics's current ratio?
vTv Therapeutics's current ratio was 13.54 at the end of fiscal 2025: current assets were 13.54 times current liabilities.